Cargando…

Chronic Myeloid Leukemia Data at ASH 2021: A Podcast on Patient Unmet Needs and Later-Line Treatment Developments

Detalles Bibliográficos
Autor principal:	Breccia, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918210/ https://www.ncbi.nlm.nih.gov/pubmed/35099709 http://dx.doi.org/10.1007/s12325-022-02048-x

Ejemplares similares

American Society of Hematology 2020 Podcast Collection: CML
por: Breccia, Massimo
Publicado: (2021)

American Society of Hematology 2020 Podcast Collection: MPN
por: Breccia, Massimo
Publicado: (2021)

Podcast on the Challenges and Recommendations to Address Unmet Needs in MS for LGBTQ+ Populations in the United States
por: Conte, William L., et al.
Publicado: (2023)

Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast
por: Landgren, Ola, et al.
Publicado: (2023)

Imatinib improved the overall survival of chronic myeloid leukemia patients in low- and middle-income countries: A therapeutic goal has been reached
por: Breccia, Massimo
Publicado: (2020)

Bosutinib for Chronic Myeloid Leukemia
por: Breccia, Massimo, et al.
Publicado: (2015)

A Podcast Discussing Aldosterone and Mineralocorticoid Receptor Antagonists in 2021: A Paradigm Shift
por: Epstein, Murray
Publicado: (2022)

American Society of Clinical Oncology 2021 Podcast: HR+, HER2− Breast Cancer
por: Cheung, Kwok-Leung
Publicado: (2021)

The FIDELIO Study Podcast
por: Toto, Robert, et al.
Publicado: (2022)

Chronic myeloid leukemia data from India
por: Bansal, Shweta, et al.
Publicado: (2013)

Real-World Analysis of the Therapeutic Management and Disease Burden in Chronic Myeloid Leukemia Patients with Later Lines in Italy
por: Breccia, Massimo, et al.
Publicado: (2022)

Patient and Healthcare Professional Perspectives from ESMO 2021 on Bladder and Kidney Cancer: A Podcast
por: Filicevas, Alex, et al.
Publicado: (2022)

Systematic review of dasatinib in chronic myeloid leukemia
por: Breccia, Massimo, et al.
Publicado: (2013)

How I Treat Chronic Inflammatory Demyelinating Polyneuropathy Podcast
por: Desai, Urvi
Publicado: (2023)

Treatment-free remission in chronic myeloid leukemia: the patient perspective and areas of unmet needs
por: Sharf, Giora, et al.
Publicado: (2020)

The Economic Burden of Chronic Myeloid Leukemia in Patients with Later Lines: Findings from a Real-World Analysis in Italy
por: Breccia, Massimo, et al.
Publicado: (2022)

Contraceptive preferences and unmet need for contraception in midlife women: where are the data?
por: Harlow, Siobán D., et al.
Publicado: (2017)

Unmet Needs in Pediatric Functional Constipation
por: Sood, Manu, et al.
Publicado: (2018)

Semaglutide in Obesity: Unmet Needs in Men
por: Jensterle, Mojca, et al.
Publicado: (2023)

Unmet Needs in Preventive Treatment of Migraine
por: Bentivegna, Enrico, et al.
Publicado: (2023)

Access to care - an unmet need in headache management?
por: Tassorelli, Cristina, et al.
Publicado: (2014)

Prognostic Significance of Transcript-Type BCR - ABL1 in Chronic Myeloid Leukemia
por: Molica, Matteo, et al.
Publicado: (2020)

Italian Physicians’ Perceptions about the Role of Asciminib in Later Lines Chronic Myeloid Leukemia in Clinical Practice: A GIMEMA Survey
por: Breccia, Massimo, et al.
Publicado: (2023)

Podcast on the Management of Adverse Events Associated with Lorlatinib
por: Bauer, Todd M., et al.
Publicado: (2022)

Cultivating a Community of Practice through Podcasting
por: Zumach, Gregory M., et al.
Publicado: (2020)

A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phase
por: García-Gutiérrez, Valentin, et al.
Publicado: (2022)

Physicians’ attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients
por: Breccia, Massimo, et al.
Publicado: (2017)

Targeting Menin and CD47 to Address Unmet Needs in Acute Myeloid Leukemia
por: Matthews, Andrew H., et al.
Publicado: (2022)

Refining targeted therapies in chronic myeloid leukemia: development and application of nilotinib, a step beyond imatinib
por: Breccia, Massimo, et al.
Publicado: (2008)

Towards a New Understanding of Unmet Medical Need
por: Zhang, Kyann, et al.
Publicado: (2021)

Meeting the unmet needs of disabled adults with cerebral palsy
por: Werner, Shirli
Publicado: (2022)

ASHE December 2021: Reflections on our first year with an eye on the future
por: Bearman, Gonzalo, et al.
Publicado: (2022)

Podcast on Lorlatinib as a First-Line Treatment Option for Patients with ALK-Positive Metastatic NSCLC with Brain Metastasis
por: Liu, Geoffrey, et al.
Publicado: (2023)

First Line Medical Treatment of Metastatic Renal Cell Carcinoma: A Podcast on Choosing Wisely and Managing Safely
por: Ivanyi, Philipp, et al.
Publicado: (2023)

Diabetes Therapy Podcast Collection: Language Matters in Diabetes
por: Kalra, Sanjay, et al.
Publicado: (2021)

Biosimilars for Rheumatoid Arthritis: Riding the 2023 Wave [Podcast]
por: Cohen, Stanley B, et al.
Publicado: (2023)

Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma
por: Leahey, Ann-Marie, et al.
Publicado: (2021)

Diabetes Therapy Podcast: Real-World Data for Glucose Sensing Technologies in Type 1 Diabetes
por: Oliver, Nick
Publicado: (2022)

Chronic myeloid leukemia in India
por: Goldman, John M.
Publicado: (2013)

Commentary on the ASH ISTH NHF WFH 2021 guidelines on the diagnosis of VWD: reflections based on recent contemporary test data
por: Favaloro, Emmanuel J.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pg5o7vgael1l5a1sj5a7107hfi